13.30 – CHAIR INTRODUCTION

Chair: Bastian Nießing, Group Manager Automation in Life Sciences, Fraunhofer IPT

13.35 – PRESENTATION: The Future of Automation in Cell and Gene Therapy 

• Explanation of the Biophorum’s 2022 robotics road map
• Current status of mobile robotics
• What is holding back the implementation of modern robotics

Speaker: David Wolton, Engineering Technology Lead, Takeda

13:50 – PRESENTATION: Shape Your Cell-Based Therapy Path to GMP: Current and Future Technologies Towards Commercialisation

• Challenges and solutions for cGMP manufacturing
• A standardized, systematic approach to commercialization
• Current and future technologies

Speaker: Marcos Langtry, Director of Commercial Development, Allogeneic Cell Therapy, Lonza

14:05 – PRESENTATION: The Role of Automated Bioprocessing Within ATMP Development and Production

• AZ activity update in Cell Therapy space
• Overview of current approaches to automation and the recent associated developments
• Defining what’s needed moving forward and how AZ are looking to collaborate

Speaker: Michael Delahaye, Director, Team Leader, Cell Therapy Bioprocessing, AstraZeneca

14:20 – PRESENTATION

Speaker: TBC

14:20 – SPEAKER Q&A

Joined by:

David Wolton, Engineering technology lead, Takeda

Marcos Langtry, Director of Commercial Development, Allogeneic Cell Therapy, Lonza

Michael Delahaye, Director, Team Leader, Cell Therapy Bioprocessing, AstraZeneca